Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
SpaceX shareholders approve 5-for-1 stock split ahead of much-awaited IPO: Report
SpaceX shareholders have approved a five-for-one stock split. The company is preparing for a major stock market debut. SpaceX aims to list its shares on